CommercialCoverageMedium impact
Medical Policy Update for August 23, 2022
Blue Cross NC·NC · Gastroenterology, OB-GYN, Oncology +2 more·Medical Policy
Effective date
Aug 23, 2022
We identified it
Jun 16, 2026
Summary
Blue Cross NC updated five medical policies effective August 23, 2022, including minor clarifications to capsule endoscopy and facet joint denervation policies, addition of exclusion for Aptima BV screening in vaginitis diagnosis, archival of Quantose IGT test, and coverage addition for Lutetium 177 cancer therapy.
Action Required
Immediately: Stop billing for Aptima BV bacterial vaginosis screening as it is now specifically excluded from reimbursement. Stop billing for Quantose Impaired Glucose Tolerance (IGT) tests as the policy has been archived and test is no longer available. Update billing system to include coverage for Lutetium 177 (Lu 177) vipivotide tetraxetan (Pluvicto) for oncology treatments.